A Spotlight on the Underlying Activation Mechanisms of the NLRP3 Inflammasome and its Role in Atherosclerosis: A Review

被引:0
|
作者
Anam Liaqat
Muhammad Asad
Fatima Shoukat
Arif-Ullah Khan
机构
[1] Riphah International University,Riphah Institute of Pharmaceutical Sciences
[2] National Institute of Heart Diseases,Armed Forces Institute of Cardiology
来源
Inflammation | 2020年 / 43卷
关键词
atherosclerosis; cardiovascular disease; inflammasome; inflammation; interleukin-1β;
D O I
暂无
中图分类号
学科分类号
摘要
The world’s number one cause of death is cardiovascular diseases. The pathogenesis of different disease entities in the cardiovascular disease spectrum is complicated and multifactorial. Inflammation in these complicated etiologies serves as a key position and is a significant cause of atherosclerosis, which contributes to the underlying pathology. Therefore, therapeutic targeting of inflammatory pathways in patients with cardiovascular diseases such as atherosclerosis enhances cardiovascular results. Inflammasomes are intracellular protein complexes engaged in atherosclerosis pathogenesis and activated by multiple danger signals. Emerging proof has revealed that Nod-like receptor protein 3 (NLRP3) inflammasome, which regulates caspase-1 activation and later pro-interleukin processing, triggers inflammatory reactions in the vascular wall and leads to atherosclerotic plaque formation. Inflammasome-mediated signaling interference could decrease inflammation and mitigate illness severity. In this section, we provide an overview of the present literature on the underlying mechanisms leading to the activation of NLRP3 inflammasome and the role of NLRP3 inflammasome in the progression of atherogenesis and highlight the possibility of therapeutic interventions due to mechanisms involved in the of inhibition of NLRP3 activation.
引用
收藏
页码:2011 / 2020
页数:9
相关论文
共 50 条
  • [1] A Spotlight on the Underlying Activation Mechanisms of the NLRP3 Inflammasome and its Role in Atherosclerosis: A Review
    Liaqat, Anam
    Asad, Muhammad
    Shoukat, Fatima
    Khan, Arif-Ullah
    INFLAMMATION, 2020, 43 (06) : 2011 - 2020
  • [2] Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
    Jiang, Chunteng
    Xie, Santuan
    Yang, Guang
    Wang, Ningning
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 7143 - 7172
  • [3] Molecular mechanisms of NLRP3 inflammasome activation and its regulation
    Bratkovic, I. Hafner
    Susjan, P.
    Lainscek, D.
    Tapia-Abellan, A.
    Pelegrin, P.
    Jerala, R.
    FEBS OPEN BIO, 2021, 11 : 56 - 57
  • [4] Molecular mechanisms of NLRP3 inflammasome activation and its regulation
    Bratkovic, Iva Hafner
    Susjan, Petra
    Pelegrin, Pablo
    Jerala, Roman
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 66 - 66
  • [5] The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases
    Dadkhah, Mina
    Sharifi, Mohammadreza
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2025, 44 (02) : 98 - 111
  • [6] Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation
    Xu, Ziwei
    Chen, Zi-mo
    Wu, Xiaoyan
    Zhang, Linjie
    Cao, Ying
    Zhou, Pingzheng
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [7] Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease
    Zhang, Yidan
    Zhao, Yuan
    Zhang, Jian
    Yang, Guofeng
    NEUROCHEMICAL RESEARCH, 2020, 45 (11) : 2560 - 2572
  • [8] Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer’s Disease
    Yidan Zhang
    Yuan Zhao
    Jian Zhang
    Guofeng Yang
    Neurochemical Research, 2020, 45 : 2560 - 2572
  • [9] Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy
    Higashimori, A.
    Watanabe, T.
    Nadatani, Y.
    Takeda, S.
    Otani, K.
    Tanigawa, T.
    Yamagami, H.
    Shiba, M.
    Tominaga, K.
    Fujiwara, Y.
    Arakawa, T.
    MUCOSAL IMMUNOLOGY, 2016, 9 (03) : 659 - 668
  • [10] NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
    Chen, Pengfei
    Li, Xia
    FRONTIERS IN PHARMACOLOGY, 2024, 15